CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity
- PMID: 18794900
- PMCID: PMC2587138
- DOI: 10.1038/nature07179
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity
Abstract
Aberrant activation of the canonical WNT/beta-catenin pathway occurs in almost all colorectal cancers and contributes to their growth, invasion and survival. Although dysregulated beta-catenin activity drives colon tumorigenesis, further genetic perturbations are required to elaborate full malignant transformation. To identify genes that both modulate beta-catenin activity and are essential for colon cancer cell proliferation, we conducted two loss-of-function screens in human colon cancer cells and compared genes identified in these screens with an analysis of copy number alterations in colon cancer specimens. One of these genes, CDK8, which encodes a member of the mediator complex, is located at 13q12.13, a region of recurrent copy number gain in a substantial fraction of colon cancers. Here we show that the suppression of CDK8 expression inhibits proliferation in colon cancer cells characterized by high levels of CDK8 and beta-catenin hyperactivity. CDK8 kinase activity was necessary for beta-catenin-driven transformation and for expression of several beta-catenin transcriptional targets. Together these observations suggest that therapeutic interventions targeting CDK8 may confer a clinical benefit in beta-catenin-driven malignancies.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2587138/bin/nihms-58283-f0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2587138/bin/nihms-58283-f0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2587138/bin/nihms-58283-f0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2587138/bin/nihms-58283-f0004.gif)
Comment in
-
Cancer: Entangled pathways.Nature. 2008 Sep 25;455(7212):479-80. doi: 10.1038/455479a. Nature. 2008. PMID: 18818647 No abstract available.
Similar articles
-
CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.Int J Cancer. 2010 Jun 15;126(12):2863-73. doi: 10.1002/ijc.24908. Int J Cancer. 2010. PMID: 19790197 Free PMC article.
-
Role of CDK8 and beta-catenin in colorectal adenocarcinoma.Oncol Rep. 2010 Jul;24(1):285-91. Oncol Rep. 2010. PMID: 20514474
-
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer.EBioMedicine. 2016 Nov;13:113-124. doi: 10.1016/j.ebiom.2016.10.026. Epub 2016 Oct 19. EBioMedicine. 2016. PMID: 27789274 Free PMC article.
-
Revving the Throttle on an oncogene: CDK8 takes the driver seat.Cancer Res. 2009 Oct 15;69(20):7899-901. doi: 10.1158/0008-5472.CAN-09-1704. Epub 2009 Oct 6. Cancer Res. 2009. PMID: 19808961 Free PMC article. Review.
-
Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells.Toxicology. 2013 Oct 4;312:36-47. doi: 10.1016/j.tox.2013.07.013. Epub 2013 Jul 30. Toxicology. 2013. PMID: 23907061 Review.
Cited by
-
Highlighting the Major Role of Cyclin C in Cyclin-Dependent Kinase 8 Activity through Molecular Dynamics Simulations.Int J Mol Sci. 2024 May 15;25(10):5411. doi: 10.3390/ijms25105411. Int J Mol Sci. 2024. PMID: 38791449 Free PMC article.
-
Cdk8/CDK19 promotes mitochondrial fission through Drp1 phosphorylation and can phenotypically suppress pink1 deficiency in Drosophila.Nat Commun. 2024 Apr 18;15(1):3326. doi: 10.1038/s41467-024-47623-8. Nat Commun. 2024. PMID: 38637532 Free PMC article.
-
Hit discovery of potential CDK8 inhibitors and analysis of amino acid mutations for cancer therapy through computer-aided drug discovery.BMC Chem. 2024 Apr 13;18(1):73. doi: 10.1186/s13065-024-01175-6. BMC Chem. 2024. PMID: 38615023 Free PMC article.
-
Unveiling the impact of CDK8 on tumor progression: mechanisms and therapeutic strategies.Front Pharmacol. 2024 Mar 28;15:1386929. doi: 10.3389/fphar.2024.1386929. eCollection 2024. Front Pharmacol. 2024. PMID: 38606172 Free PMC article. Review.
-
Mediator kinase module proteins, genetic alterations and expression of super-enhancer regulated genes in colorectal cancer.Pharmacol Rep. 2024 Jun;76(3):535-556. doi: 10.1007/s43440-024-00589-2. Epub 2024 Apr 11. Pharmacol Rep. 2024. PMID: 38602606
References
-
- Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell. 2000;103:311–20. - PubMed
-
- Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med. 2002;8:1323–7. - PubMed
-
- Vogelstein B, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32. - PubMed
-
- van de Wetering M, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002;111:241–50. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials